Similar articles

• Event rates in trials of patients with type 2 diabetes.

  Preiss D, Sattar N, McMurray JJ. Preiss D, et al. JAMA. 2010 Feb 24;303(8):732-3; author reply 733. doi: 10.1001/jama.2010.138. JAMA. 2010. PMID: 20179281 No abstract available.
• Variation in event rates in trials of patients with type 2 diabetes.

  Psaty BM, Prentice RL. Psaty BM, et al. JAMA. 2009 Oct 21;302(15):1698-700. doi: 10.1001/jama.2009.1497. JAMA. 2009. PMID: 19843906 No abstract available.
• [Insulin in the diabetic heart patient, only the glycemic results count].

  Fredenrich A. Fredenrich A. Soins. 2006 Mar;(703 Suppl 1):1S18-20. Soins. 2006. PMID: 16604812 French. No abstract available.
• [Insulin therapy in adult-onset diabetes].

  Taskinen MR. Taskinen MR. Duodecim. 1990;106(9):766-73. Duodecim. 1990. PMID: 1670369 Review. Finnish. No abstract available.
• [Impact of antidiabetic therapy on the risk of cardiovascular diseases and their complications in patients with type 2 diabetes mellitus].

  Ametov AS, P'ianykh OP, Chernikova NA. Ametov AS, et al. Ter Arkh. 2010;82(8):71-5. Ter Arkh. 2010. PMID: 20873250 Review. Russian.